This inventor holds 12 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignees: Valneva Austria Gmbh, Valneva Se. Active years: 2018-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2025
Title: Wolfgang Schüler: Innovator in Immunogenic Polypeptides
Introduction
Wolfgang Schüler is a prominent inventor based in Vienna, Austria. He has made significant contributions to the field of immunology, holding a total of 12 patents. His work focuses on developing innovative solutions for treating infections through the use of immunogenic polypeptides.
Latest Patents
Among his latest patents is the invention titled "Multivalent OspA polypeptides and methods and uses relating thereto." This invention relates to an immunogenic polypeptide, a nucleic acid encoding the same, and a pharmaceutical composition that can be used as a medicament, particularly a vaccine. It also outlines methods for treating or preventing infections. Another notable patent is "Mutant fragments of OspA and methods and uses relating thereto." This invention involves a polypeptide comprising a mutant fragment of an outer surface protein A (OspA), along with a nucleic acid coding for it. The patent details a pharmaceutical composition for use as a medicament and methods for treating or preventing infections.
Career Highlights
Wolfgang Schüler has worked with notable companies in the biotechnology sector, including Valneva Austria GmbH and Valneva SE. His experience in these organizations has allowed him to advance his research and contribute to the development of effective medical solutions.
Collaborations
Throughout his career, Wolfgang has collaborated with esteemed colleagues such as Urban Lundberg and Andreas Meinke. These partnerships have fostered innovation and have been instrumental in the success of his projects.
Conclusion
Wolfgang Schüler's contributions to immunology through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in medical treatments and vaccines.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
